PiSA USA
About PiSA USA
Categories
-
US -
2023On CPHI since
-
5000+Employees
Company types
Meet us at
CPHI Milan 2024
Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
Products from PiSA USA (1)
-
Product Injectables & Oral Solutions
PiSA’s Oncological and Immunosuppressant Manufacturing facility can currently produce 10 million doses of injectables and 500 million doses of oral solids annually. PiSA’s Immunosuppressant facility has the capacity to produce 200 million capsules, tablets, and vials.
PiSA USA Resources (1)
-
Video High-Volume Oral Dose & Injectable Manufacturing - PiSA USA
PiSA’s Oncological and Immunosuppressant Manufacturing facility can currently produce 10 million doses of injectables and 500 million doses of oral solids annually. PiSA’s Immunosuppressant facility has the capacity to produce 200 million capsules, tablets, and vials.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance